Drugs with this side effect
- 1,25(OH)2D3
- 4-PBA: common
- 4-methylpyrazole
- 5-ASA: postmarketing, rare, 1.5% - 66%
- 5-aza-2'-deoxycytidine: 6.17% - 14.5%
- 5-azacytidine: very common, 0% - 15.5%
- 5-fluorocytosine
- ALX 111
- AMD3100: common
- APAs
- Anidulafungin: 6.11% - 12.8%
- BCNU: 8% - 8.33%
- Benicar-HCT
- Bivalirudin: 0.8% - 4.83%
- CAS 76095-16-4: 1.6%
- CAS 76420-72-9
- CGP 19835A: very common
- Cancidas: 1.4% - 12%
- Depreotide
- Diane-35
- EACA
- Enfuvirtide: 3.7% - 4.7%
- Eptifibatide: 0.9%
- Estrofem
- FK463: 1.98% - 34.9%
- FdUrd
- Fe(III: postmarketing, 1.4% - 9%
- Gd-DTPA
- Gd-EOB-DTPA
- Goserelin: 0% - 11%
- Humalog: 7.41% - 8.14%
- ICI 182,780: 11.6% - 11.8%
- Implanon: 10.9%
- K779: 1% - 23%
- Kaluril
- L-Dmp
- LY146032: postmarketing, common, 3.4% - 5.83%
- Lantus
- Leuprorelin: postmarketing
- LiOH
- Lisinopril: postmarketing, uncommon, 2.2%
- MK-462
- Meropenem anhydrous
- Metrodin: postmarketing, common, 0.537% - 23.2%
- MnDPDP
- N-carbamylglutamate
- NTBC
- NovoLog: 0% - 5%
- NuvaRing
- Octreotide: very common
- Oestrogen: uncommon, 0.716% - 23%
- Optison: uncommon
- Org 37462
- PCI-32765
- PGE2
- Photofrin: 1.45% - 20%
- Photofrin II: common
- Romidepsin: 2.13% - 13.7%
- SOM230: 23.2% - 25%
- SU5416: 11%
- Sativex
- Saxagliptin
- Signifor: 23.2% - 25%
- SonoVue
- Stalevo 50
- Supremon
- Symlin
- TPGS
- Triphasil
- Triptorelin: 1.1%
- Trisequens
- UDCA: postmarketing, 6.2% - 43.2%
- VACV: 1% - 12%
- Vancocine: 15%
- Vitrum: 3%
- abacavir
- abacavir-lamivudine
- acamprosate: common, frequent
- acarbose
- acebutolol
- acetaminophen
- acitretin: postmarketing
- actinomycin D
- acyclovir: common
- adefovir: 9%
- adefovir dipivoxil: postmarketing, common, 9%
- agomelatine
- albendazole: 0% - 6%
- alendronate: 0% - 6.6%
- alfuzosin: common, 1.48%
- aliskiren
- allopurinol
- almotriptan: postmarketing
- alpha-methyl-p-tyrosine
- alprazolam: frequent
- ambrisentan: common, 2.99% - 3.08%
- amiloride
- aminophylline: 12% - 21%
- amiodarone
- amisulpride: 1%
- amlodipine: 1.6%
- amlodipine besylate: 1.6%
- amoxapine
- amoxicillin: 0.331% - 0.98%
- amphetamine
- amphotericin B: 7% - 21.8%
- amprenavir: common, 0% - 2%
- amsacrine
- anagrelide: 16.5% - 17%
- anastrozole: 5.69% - 8.92%
- anthracycline: 3% - 23%
- apraclonidine
- aprepitant
- argatroban: 1.6% - 3.6%
- aripiprazole
- arsenic
- arsenic trioxide: common
- articaine
- atazanavir: common, 4% - 11%
- atomoxetine: very common, 7% - 18%
- atorvastatin: 0% - 3.8%
- atovaquone: 4% - 21%
- atropine
- auranofin: 14%
- axitinib: 1% - 14%
- azathioprine
- azelastine: postmarketing
- azithromycin: 1.9% - 32.2%
- aztreonam: 6.85%
- baclofen
- balsalazide: 6% - 12.1%
- belinostat: 1% - 11%
- benazepril
- bendamustine
- bepridil: 3.02%
- bexarotene: common, 3.77% - 11%
- bezafibrate: 6% - 14%
- bicalutamide: 8% - 11%
- bicarbonate
- bisacodyl
- bisoprolol: 2.1%
- boceprevir: common
- bortezomib: 0% - 16%
- bosentan: uncommon
- bosutinib: 33.4% - 37%
- bretylium
- bromcresol green
- bromocriptine: postmarketing, rare
- budesonide: 2% - 16.8%
- bumetanide: 0.2%
- bupivacaine: 1.32% - 2.16%
- buprenorphine
- bupropion: 1% - 9%
- busulfan: 72%
- butoconazole
- butorphanol: infrequent
- cabazitaxel: 0% - 2%
- cabergoline: 5% - 8.23%
- cabozantinib: 1% - 27%
- canagliflozin
- candesartan
- candesartan cilexetil: 1% - 1.7%
- capecitabine: 1% - 35%
- captopril
- carbamazepine: postmarketing, rare
- carbidopa
- carboplatin: 17%
- carnitine: 5% - 21%
- carvedilol: 0.3% - 7.2%
- cefaclor: 3.4% - 4.67%
- cefadroxil
- cefazolin
- cefdinir
- cefditoren
- cefepime
- cefixime: 3% - 5%
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime: postmarketing
- cefprozil: 0.9% - 1%
- ceftaroline
- ceftazidime: uncommon
- ceftobiprole
- ceftriaxone
- cefuroxime: postmarketing
- cefuroxime axetil
- celecoxib: 4% - 9%
- cephalexin
- cephem
- cerivastatin: 2.5%
- cetirizine: 4.4% - 6.3%
- cevimeline: 7.6%
- chlorambucil
- cidofovir
- cilazapril
- cilostazol: 4% - 5%
- cinacalcet: 12%
- cinoxacin
- ciprofloxacin: rare, uncommon
- citalopram: 1% - 3.2%
- cladribine: 4% - 6%
- clarithromycin: postmarketing, common, 3%
- clindamycin: postmarketing
- clindamycin phosphate
- clofarabine: common
- clomipramine: common, 11% - 13%
- clonazepam: 1%
- clonidine: 1% - 2%
- clopidogrel: common, 0.3% - 2.8%
- cobicistat: common
- codeine
- colchicine: postmarketing
- colesevelam: 5%
- colestimide: common
- colestipol
- colestyramine
- conjugated estrogens: postmarketing
- copolymer 1
- cortisol
- cyclobenzaprine
- cyproterone
- cysteamine: postmarketing, common, 0% - 14%
- cytarabine: 8.56% - 15.2%
- dabigatran
- dabigatran etexilate
- dabrafenib: 0% - 33%
- dalbavancin
- dalteparin: 0.771% - 1.15%
- dantrolene
- dapsone
- darifenacin: 2.37% - 3.89%
- darunavir: 0.8% - 10%
- dasatinib: 0% - 12%
- deferasirox: common, 14.1% - 28%
- deferiprone
- deferoxamine: uncommon
- degarelix
- delamanid
- delavirdine
- delta 9-THC
- demethyl
- deprenyl: 4%
- desflurane: postmarketing
- desloratadine
- desmopressin: 0.65% - 5%
- desogestrel
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine: postmarketing
- dexrazoxane
- dextromethorphan
- dextrorphan
- diazepam
- diazoxide
- diclofenac: postmarketing, common, 0% - 5.93%
- dicloxacillin
- dicyclomine: postmarketing
- didanosine: postmarketing, 7% - 13%
- digoxin: 0%
- dihydrocodeine: common
- dihydroergotamine: infrequent
- dimercaprol
- dipyridamole: 0.7%
- docetaxel: postmarketing, rare, 0% - 9%
- dofetilide: 3%
- dolasetron: 3.15% - 10.2%
- dolutegravir
- donepezil: postmarketing, frequent
- dorzolamide
- doxazosin: 0% - 2.4%
- doxepin: infrequent
- doxorubicin: postmarketing, common, 0% - 8.2%
- doxycycline
- dronedarone: 4%
- duloxetine: common, frequent, 2% - 6%
- efavirenz: common, 0% - 5%
- eletriptan: 1% - 2%
- eltrombopag: 12%
- elvitegravir: common
- emtricitabine: postmarketing, common, 10%
- entacapone: common, 7% - 8.1%
- entecavir
- eplerenone: 1%
- eprosartan: 2%
- ergonovine
- eribulin
- erlotinib: 1% - 11%
- ertapenem: 3% - 4.7%
- erythromycin
- erythromycin lactobionate
- erythromycin stearate
- eslicarbazepine
- eslicarbazepine acetate
- esomeprazole magnesium: 2.7% - 3.8%
- estazolam: 1%
- estradiol: postmarketing, common, 0% - 16%
- estradiol valerate
- ethambutol
- ethionamide
- ethosuximide
- etidronate
- etodolac
- etoposide: 0 to 2 - 7%
- etoposide phosphate: 7%
- etoricoxib: postmarketing
- etravirine: 3%
- everolimus: common, very common, 0% - 36%
- exemestane: common, 2.8% - 11%
- exenatide: postmarketing, uncommon, 0.897% - 3.61%
- ezetimibe: postmarketing, 2.7% - 3.5%
- famciclovir: 0% - 7.9%
- famotidine
- febuxostat: uncommon
- felbamate: 5.3%
- felodipine
- fenofibrate: postmarketing, common, 2.52% - 5.1%
- fenofibric acid: 4.6%
- fenoldopam
- fenoprofen
- fentanyl: 2.9% - 14.6%
- ferumoxytol: postmarketing, 1.3% - 1.4%
- fesoterodine
- fexofenadine: 0.7% - 1.3%
- fidaxomicin: 3.95% - 6%
- flecainide: 1% - 3.3%
- flucloxacillin
- fluconazole: postmarketing, 1.6% - 6%
- fludarabine: 8% - 10%
- flunisolide
- fluorescein: postmarketing, uncommon
- fluoxetine: 4.9% - 9.6%
- flurbiprofen
- fluticasone: 0% - 3%
- fluticasone propionate
- fluvastatin: common, 0.7% - 4.9%
- fluvoxamine: common, frequent, 1% - 5.6%
- fondaparinux: rare, 1.27% - 1.44%
- formoterol
- fosamprenavir: common
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril: uncommon
- fosinoprilat
- fotemustine
- frovatriptan: frequent
- furosemide
- fusidic acid: 2.9% - 5.3%
- gabapentin: postmarketing, 1.8% - 23%
- gadobenate dimeglumine
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium: postmarketing
- gadopentetate
- gadoversetamide
- galantamine: 2.4% - 5%
- ganciclovir: 7.6% - 15%
- gatifloxacin
- gefitinib: 2.91% - 7.55%
- gemfibrozil: postmarketing, 6.4% - 9.8%
- gemifloxacin: 0.2% - 1.1%
- glibenclamide
- gliclazide: 1.1% - 1.4%
- glimepiride
- glipizide: postmarketing
- glutamine: 0% - 25%
- glycerol phenylbutyrate: 4.44% - 6.82%
- glycopyrrolate
- gonadorelin: common, 5.08% - 11.6%
- granisetron: 3% - 11%
- guanfacine: postmarketing, 10% - 11%
- halofantrine: 8.5% - 10%
- hepatitis B vaccines: common
- hydrochlorothiazide: 1.2%
- hydrocodone: 1.57% - 2.65%
- hydromorphone: 2.01% - 4.65%
- hydroxybutyrate
- hydroxychloroquine
- ibandronate: 2.1% - 7.8%
- ibuprofen
- icodextrin: 6% - 8%
- idarubicin
- ifosfamide: postmarketing
- imatinib: very common, 0% - 57.2%
- imipramine
- imiquimod: postmarketing, uncommon, 0.3% - 1.12%
- indapamide
- indinavir: 5.1% - 16.6%
- indomethacin: 1% - 2%
- insulin detemir: 2.6% - 13.4%
- iodixanol
- iohexol
- iopromide
- ipratropium bromide
- irbesartan: 0.8% - 1.7%
- irbesartan-hydrochlorothiazide: 0.8% - 1.7%
- irinotecan: 0.7% - 67.7%
- iron sucrose
- isomannide
- isosorbide-5-mononitrate
- itraconazole: postmarketing, 0% - 7%
- ivacaftor: 15.6%
- ivermectin: 0.9%
- ixabepilone: 13% - 14%
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- ketotifen
- labetalol: 0% - 2%
- lamivudine: 11%
- lamotrigine: 3% - 10%
- lanreotide: postmarketing, 6.48% - 18.9%
- lansoprazole: 0% - 9%
- lanthanum: 5%
- lanthanum carbonate: 3% - 17%
- lapatinib: very common, 12%
- lasofoxifene: uncommon
- leflunomide: postmarketing, common, 4% - 8%
- lenalidomide: postmarketing, very common, 3.73% - 10.9%
- lercanidipine
- letrozole: uncommon, 5% - 9%
- leucovorin
- levetiracetam: 3.7%
- levodopa/carbidopa
- levonorgestrel: postmarketing, 2.5% - 20.9%
- linaclotide: 1%
- linezolid: 0% - 1.6%
- liraglutide
- lithium
- lithium carbonate
- lomefloxacin: 1.2%
- lomitapide
- loperamide: postmarketing
- loratadine
- losartan: 1.7%
- lovastatin: 2% - 2.5%
- lubiprostone: 3% - 8%
- lurasidone: frequent
- lymecycline
- maprotiline
- maraviroc: 8.2%
- mebendazole
- meclofenamate
- medroxyprogesterone
- medroxyprogesterone acetate
- mefenamic acid
- mefloquine: postmarketing
- megestrol
- melatonin
- meloxicam: 1.1% - 28.1%
- memantine: 2%
- meropenem
- mesna: 11.8% - 18%
- metformin: 4.02% - 7.39%
- methadone
- methohexital
- methotrexate
- methsuximide
- methylene blue
- methylergometrine
- methylnaltrexone: very common
- methylphenidate: postmarketing, common, 0.7% - 7.14%
- methylprednisolone
- methylprednisolone sodium succinate
- methysergide
- metolazone
- metoprolol: common
- metronidazole: very rare, postmarketing, 3.75% - 5%
- metyrapone: rare
- mexiletine: 1.2% - 1.5%
- miconazole: 2% - 2.7%
- midodrine
- mifepristone
- miglitol
- miglustat: 0% - 67%
- milnacipran: 3%
- minocycline: 0% - 1.2%
- mipomersen: 3%
- mirabegron: 0.6% - 1.4%
- mirtazapine: frequent
- misoprostol
- mitoxantrone: 4% - 15%
- moclobemide
- modafinil: postmarketing
- moexiprilat
- mometasone: 2% - 6%
- mometasone furoate: 2% - 3%
- monomethylfumarate: 18%
- monomycin
- montelukast
- morphine: 3%
- moxifloxacin: 2%
- moxonidine
- mupirocin
- mycophenolate mofetil: 7.3% - 62.5%
- mycophenolic acid: 23% - 62.5%
- nabilone
- nabumetone: 12%
- nafcillin
- nalbuphine
- nalidixic acid
- naltrexone: postmarketing
- naproxen: postmarketing
- nateglinide: common
- nebivolol
- nedocromil sodium
- nefazodone
- nelarabine: 0% - 9%
- nelfinavir: postmarketing
- nevirapine: common, 0.1% - 3%
- niacin
- nicardipine: 0.7%
- nicorandil: uncommon, common
- nicotine: 3%
- nifedipine: 1.2% - 1.4%
- nilotinib: 0% - 10%
- nilutamide
- nitazoxanide: 6.6% - 7.8%
- nitrite
- nitrofurantoin
- nitroglycerin
- nitroprusside
- nizatidine: 7.5%
- norethisterone
- norfloxacin
- o291
- ofloxacin
- olanzapine: infrequent, 3% - 6%
- olmesartan: postmarketing, common
- olmesartan medoxomil
- olopatadine: postmarketing
- olsalazine: 1.13% - 10.1%
- omeprazole: common, 1% - 5.8%
- ondansetron
- orlistat: 25.5%
- oseltamivir: postmarketing, 2.2% - 24%
- oxacillin
- oxaliplatin: very common, 1% - 31%
- oxaprozin
- oxazepam
- oxcarbazepine: common, 3% - 13%
- oxybutynin: common, 1.5% - 2.5%
- oxycodone
- oxymorphone: 2.5% - 3%
- paclitaxel
- paliperidone
- palonosetron: 0.158% - 1.55%
- pamidronate: common, 0% - 24.3%
- pantoprazole: 1% - 6.2%
- parecoxib
- paricalcitol
- paroxetine: common, 0.3% - 7%
- pazopanib: 0% - 11%
- pemetrexed: common
- penciclovir: 0% - 7.9%
- penicillin
- pentamidine
- pentosan polysulfate: 2%
- pentostatin: 4% - 16%
- pentoxifylline
- pergolide: frequent, 5.8%
- perhexiline
- perindopril: 2.7%
- perindopril erbumine: 2.7%
- permethrin
- phentolamine: common
- phenylbutyric acid
- phosphate: 23% - 25%
- pilocarpine: 3% - 4%
- pimecrolimus: 0.299% - 4.41%
- pindolol
- piperacillin: rare
- pirbuterol
- pirfenidone
- piroxicam: 4.7%
- pitavastatin: postmarketing
- pixantrone
- ponatinib: 3.6% - 49%
- posaconazole: 2% - 18%
- potassium
- pralatrexate
- pramipexole
- pravastatin: postmarketing, 0.9% - 5.4%
- praziquantel: postmarketing
- prednisone
- pregabalin: frequent
- procainamide
- procarbazine
- progesterone: 10% - 20%
- proguanil
- propafenone: postmarketing, 0.4% - 8%
- propoxyphene
- propoxyphene napsylate
- propranolol: 0.4% - 3.5%
- prostacyclin: 5%
- prostaglandin
- prucalopride: very common
- pyridostigmine: 7%
- quetiapine: 1% - 7%
- quinapril: 0.064%
- quinaprilat: 0.064%
- quinidine
- rabeprazole: 3.6% - 5%
- raloxifene: 6.6% - 18.7%
- raltegravir
- raltitrexed: 6-8%
- ramipril
- ramiprilat
- ranolazine
- rapamycin: very common, 22% - 36%
- rasagiline: common, 2% - 5%
- rasburicase: 2.2% - 25.3%
- reboxetine: 1.87%
- regadenoson: postmarketing
- regorafenib
- repaglinide
- rescinnamine: 1.4%
- retinoic acid: 31%
- ribavirin: very common, 8% - 24%
- rifabutin: 4%
- rifapentine
- rifaximin: 7.19% - 8.57%
- rilpivirine: 2%
- riluzole: 5.1% - 7.8%
- rimantadine: 0.8% - 1.4%
- rimonabant: postmarketing
- riociguat
- risedronate: rare, 2.9% - 11.8%
- risperidone: frequent, 0% - 18%
- ritonavir: 3.4% - 8.3%
- rivaroxaban
- rivastigmine: common, 1% - 13%
- rofecoxib: 3.4% - 5.8%
- roflumilast: 1.9%
- ropinirole: frequent, 6% - 9%
- ropivacaine: 1.1% - 4.3%
- rosuvastatin: common, 2.4%
- sacrosidase
- salbutamol: postmarketing, 0% - 6.7%
- salmeterol
- salmon calcitonin acetate: postmarketing, common
- salsalate
- samarium: 6.03%
- saquinavir: common
- sertraline: postmarketing, common, 1% - 7%
- sevelamer: postmarketing, 9%
- sevelamer carbonate: postmarketing, 9%
- sevelamer hydrochloride: postmarketing, 5.2% - 9%
- sibutramine
- sildenafil
- silodosin
- simvastatin: 0.9% - 8.9%
- sitagliptin
- sodium: 23% - 36%
- sodium cromoglycate: 1.6%
- sodium ferric gluconate: 6% - 9%
- sodium nitrite
- sodium nitroprusside
- solifenacin
- sorafenib: 0% - 7%
- sotalol: 1% - 3%
- sparfloxacin: 1.8% - 2.4%
- stavudine: postmarketing, common
- strontium ranelate: postmarketing
- sugammadex
- sulfadiazine
- sulfamethoxazole
- sulfasalazine: 8%
- sumatriptan
- sunitinib: 2% - 3%
- tacrolimus: common, 1% - 59%
- tadalafil: postmarketing, 1% - 2%
- tamoxifen: 7-9% - 8.92%
- tamsulosin: 3.4%
- technetium-99m
- teduglutide
- tegaserod: 5% - 12%
- telavancin: uncommon, 2%
- telithromycin: 0.7% - 1.3%
- telmisartan: postmarketing, rare, uncommon, common
- temozolomide: common, 0% - 8.86%
- temsirolimus
- teniposide
- tenofovir: postmarketing, 4% - 22%
- tenofovir disoproxil fumarate: postmarketing, 3% - 22%
- terazosin: 1%
- terbinafine: 0% - 2.4%
- terconazole
- testosterone: postmarketing
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetraen
- tetrahydrobiopterin: postmarketing, 5.41%
- tetrofosmin: 11%
- thalidomide: 2.78% - 4.17%
- theophylline: 12% - 21%
- thiabendazole
- thiotepa
- thymidine: 0.1% - 13%
- thyroxine
- tiagabine: 5% - 7%
- tiaprofenic acid: 2.4% - 3.1%
- ticagrelor
- tigecycline: common, 4% - 6.8%
- tiludronate
- timolol
- tinidazole
- tiopronin
- tiotropium: 5% - 6%
- tipranavir: common, 3.4%
- tizanidine: frequent
- tobramycin: 12.8%
- tofacitinib
- tolcapone: frequent, 5%
- tolmetin
- tolterodine: 2.5%
- topiramate: very rare, postmarketing, 1.1% - 15%
- topotecan: postmarketing, very common, 1% - 22%
- trabectedin
- tramadol: uncommon, 0.9% - 1.4%
- trametinib: 1% - 33%
- trandolapril: postmarketing
- trandolaprilat
- tranexamic acid: 19.8%
- tranylcypromine
- travoprost
- trazodone
- treprostinil
- triamcinolone acetonide
- triazolam
- trien
- trimethadione
- trimethoprim: 1% - 2.5%
- troglitazone
- tropisetron
- trospium chloride: 1.38%
- trovafloxacin: 0% - 1%
- ulipristal: 12%
- v 1784: postmarketing, common, 2.7% - 15%
- valdecoxib: 7% - 17%
- valganciclovir: 4.27% - 6.41%
- valproate: 3% - 23%
- valrubicin
- valsartan: 1.3%
- vandetanib: 1.3% - 21%
- vardenafil
- varenicline: uncommon, 5% - 7%
- venlafaxine: 2.2% - 8%
- vigabatrin: common, 2% - 3%
- vinblastine
- vincristine: 8.43%
- vinflunine
- vinorelbine: postmarketing
- vismodegib
- voriconazole: very common, 0% - 3.24%
- warfarin
- zafirlukast: 1.8%
- zalcitabine
- zaleplon: 6%
- zanamivir
- ziconotide
- zidovudine: common, 8.51% - 21.3%
- ziprasidone: frequent, 0% - 2%
- zoledronic acid: uncommon, common, 2% - 14%
- zolmitriptan: postmarketing
- zolpidem: postmarketing, frequent, 2%
- zonisamide: 6%
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|
